Related Experiment Videos
Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors
1Department of Medical Microbiology and Virology, University of Kiel, Kiel, Germany. Mikrobio.Kiel@t-online.de
Abstract:
Bacteria belonging to the genus Klebsiella frequently cause human nosocomial infections. In particular, the medically most important Klebsiella species, Klebsiella pneumoniae, accounts for a significant proportion of hospital-acquired urinary tract infections, pneumonia, septicemias, and soft tissue infections. The principal pathogenic reservoirs for transmission of Klebsiella are the gastrointestinal tract and the hands of hospital personnel. Because of their ability to spread rapidly in the hospital environment, these bacteria tend to cause nosocomial outbreaks. Hospital outbreaks of multidrug-resistant Klebsiella spp., especially those in neonatal wards, are often caused by new types of strains, the so-called extended-spectrum-beta-lactamase (ESBL) producers. The incidence of ESBL-producing strains among clinical Klebsiella isolates has been steadily increasing over the past years. The resulting limitations on the therapeutic options demand new measures for the management of Klebsiella hospital infections. While the different typing methods are useful epidemiological tools for infection control, recent findings about Klebsiella virulence factors have provided new insights into the pathogenic strategies of these bacteria. Klebsiella pathogenicity factors such as capsules or lipopolysaccharides are presently considered to be promising candidates for vaccination efforts that may serve as immunological infection control measures.
Insights
Klebsiella pneumoniae is a major cause of hospital infections, including multidrug-resistant strains. Understanding its virulence factors may lead to new vaccines for infection control.
Area of Science:
- Microbiology
- Infectious Diseases
- Hospital Epidemiology
Background:
- Klebsiella species, particularly Klebsiella pneumoniae, are significant causes of nosocomial infections.
- These bacteria are transmitted via the gastrointestinal tract and hospital personnel, leading to outbreaks.
- The rise of multidrug-resistant strains, especially extended-spectrum beta-lactamase (ESBL) producers, limits treatment options.
Purpose of the Study:
- To review the epidemiology and pathogenicity of Klebsiella infections.
- To highlight the challenges posed by multidrug-resistant Klebsiella strains.
- To explore potential new strategies for infection control.
Main Methods:
- Review of epidemiological data on Klebsiella infections.
- Analysis of virulence factors contributing to Klebsiella pathogenicity.
- Discussion of current and potential infection control measures.
Main Results:
- Klebsiella pneumoniae is a leading cause of hospital-acquired infections like pneumonia and UTIs.
- Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella strains are increasing, complicating treatment.
- Virulence factors such as capsules and lipopolysaccharides are key to Klebsiella's pathogenic strategies.
Conclusions:
- New approaches are needed to manage Klebsiella hospital infections due to increasing resistance.
- Understanding Klebsiella virulence factors offers potential for novel vaccination strategies.
- Immunological approaches targeting pathogenicity factors may enhance infection control in healthcare settings.